Leading male genital desensitizing spray Dynamo Delay announces that its topical anesthetic treatment has once again surpassed the industry’s most stringent production standards of the United States Pharmacopeia (USP).
Consistent with the company’s ‘safety always first’ philosophy, Dynamo Delay topped the U.S.’s newest microbial requirements for Cosmetic/OTC and Pharmaceutical products, ensuring consumer protection against Burkholderia cepacia complex (Bcc), a potentially dangerous pathogen often found in water.
“We never compromise on quality and always ensure we exceed all standards,” said Dan Holman, Dynamo’s Senior Account Executive. “USP is the preeminent authority in the USA on pharmaceutical products, and we follow all of their requirements scrupulously.”
Dynamo Delay is the ultimate on-the-spot treatment for men who suffer from premature ejaculation; the endurance enhancer is made in California with Solar Power, its formulation is 35% stronger than its closest retail contenders and the spray adheres to the most stringent quality and safety standards set by the FDA.
Vice President Conde Aumman said, “Dynamo Delay is now a well-established player in this space,” noting that the company has officially incorporated the new manufactured goods standards into all of parent company Screaming O’s testing and release protocols. “We offer a better product at a much better price than the competition.”
To order Dynamo Delay visit DynamoDelay.com or Amazon.com.
